BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23054995)

  • 21. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
    Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
    Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of XDR/pre-XDR tuberculosis by genetic mutations among MDR cases from a hospital in Shandong, China.
    Wang H; Zhang X; Luo T; Li X; Tian P; Xu Y; Gao Q
    Tuberculosis (Edinb); 2014 May; 94(3):277-81. PubMed ID: 24751554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and molecular characterization of amikacin resistance among Mycobacterium tuberculosis clinical isolates from southern China.
    Islam MM; Tan Y; Hameed HMA; Liu Y; Chhotaray C; Cai X; Liu Z; Lu Z; Wang S; Cai X; Su B; Li X; Tan S; Liu J; Zhang T
    J Glob Antimicrob Resist; 2020 Sep; 22():290-295. PubMed ID: 32142951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal.
    Perdigão J; Macedo R; Machado D; Silva C; Jordão L; Couto I; Viveiros M; Portugal I
    Clin Microbiol Infect; 2014 May; 20(5):O278-84. PubMed ID: 24102832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.
    Singh AK; Maurya AK; Kant S; Umrao J; Kushwaha RA; Nag VL; Dhole TN
    J Postgrad Med; 2013; 59(3):179-85. PubMed ID: 24029194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
    Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation and Transmission Profiles of Second-Line Drug Resistance in Clinical Isolates of Drug-Resistant
    Li Q; Gao H; Zhang Z; Tian Y; Liu T; Wang Y; Lu J; Liu Y; Dai E
    Front Microbiol; 2019; 10():1838. PubMed ID: 31447823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular detection of drug resistance to ofloxacin and kanamycin in Mycobacterium tuberculosis by using multiplex allele-specific PCR.
    Kumari R; Banerjee T; Anupurba S
    J Infect Public Health; 2018; 11(1):54-58. PubMed ID: 28404233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
    Zhang D; Liu B; Wang Y; Pang Y
    Trop Med Int Health; 2014 Oct; 19(10):1259-66. PubMed ID: 25040060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan].
    Kazumi Y; Itagaki N; Ohmori M; Wada M; Hoshino H; Mitarai S; Sugawara I; Ishikawa N; Mori T
    Kekkaku; 2007 Dec; 82(12):891-6. PubMed ID: 18188977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region.
    Gikalo MB; Nosova EY; Krylova LY; Moroz AM
    J Antimicrob Chemother; 2012 Sep; 67(9):2107-9. PubMed ID: 22593564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
    Georghiou SB; Magana M; Garfein RS; Catanzaro DG; Catanzaro A; Rodwell TC
    PLoS One; 2012; 7(3):e33275. PubMed ID: 22479378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using genomics to understand the origin and dispersion of multidrug and extensively drug resistant tuberculosis in Portugal.
    Perdigão J; Gomes P; Miranda A; Maltez F; Machado D; Silva C; Phelan JE; Brum L; Campino S; Couto I; Viveiros M; Clark TG; Portugal I
    Sci Rep; 2020 Feb; 10(1):2600. PubMed ID: 32054988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal.
    Poudel A; Maharjan B; Nakajima C; Fukushima Y; Pandey BD; Beneke A; Suzuki Y
    Tuberculosis (Edinb); 2013 Jan; 93(1):84-8. PubMed ID: 23146281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
    Habibnia S; Karami-Zarandi M; Zaker S; Ghalavand Z; Doustdar F; Eslami G; Kazemian H
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.